关注
Dr. Priyanka S. Rana
Dr. Priyanka S. Rana
Kent State University, Case Western Reserve University
在 case.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance
A Alkrekchi, W Wang, PS Rana, V Markovic, K Sossey-Alaoui
Cellular Signalling, 110073, 2021
462021
Calibration and characterization of intracellular Asante Potassium Green probes, APG-2 and APG-4
PS Rana, BA Gibbons, AA Vereninov, VE Yurinskaya, RJ Clements, ...
Analytical biochemistry 567, 8-13, 2019
242019
Calibrated brightfield‐based imaging for measuring intracellular protein concentration
NJ Mudrak, PS Rana, MA Model
Cytometry Part A 93 (3), 297-304, 2018
242018
Evidence for macromolecular crowding as a direct apoptotic stimulus
PS Rana, M Kurokawa, MA Model
Journal of cell science 133 (9), jcs243931, 2020
182020
The role of WAVE2 signaling in cancer
PS Rana, A Alkrekshi, W Wang, V Markovic, K Sossey-Alaoui
Biomedicines 9 (9), 1217, 2021
162021
Staurosporine-induced apoptotic water loss is cell-and attachment-specific
MA Model, NJ Mudrak, PS Rana, RJ Clements
Apoptosis 23, 449-455, 2018
132018
A reverse-osmosis model of apoptotic shrinkage
PS Rana, MA Model
Frontiers in cell and developmental biology 8, 588721, 2020
92020
Phase separation in necrotic cells
PS Rana, NJ Mudrak, R Lopez, M Lynn, L Kershner, MA Model
Biochemical and biophysical research communications 492 (3), 300-303, 2017
92017
Targeting TGF-β signaling in the multiple myeloma microenvironment: Steering CARs and T cells in the right direction
PS Rana, DC Soler, J Kort, JJ Driscoll
Frontiers in Cell and Developmental Biology 10, 1059715, 2022
82022
Targeted deletion of kindlin-2 in mouse mammary glands inhibits tumor growth, invasion, and metastasis downstream of a TGF-β/EGF oncogenic signaling pathway
W Wang, PS Rana, A Alkrekshi, K Bialkowska, V Markovic, ...
Cancers 14 (3), 639, 2022
72022
Vactosertib, a novel TGF-β1 type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
E Malek, PS Rana, M Swamydas, M Daunov, M Miyagi, E Murphy, ...
Research Square, 2023
62023
Road testing new CAR design strategies in multiple myeloma
PS Rana, EV Murphy, J Kort, JJ Driscoll
Frontiers in Immunology 13, 957157, 2022
62022
YB1 is a major contributor to health disparities in triple negative breast cancer
PS Rana, W Wang, A Alkrekshi, V Markovic, A Khiyami, R Chan, ...
Cancers 13 (24), 6262, 2021
62021
The WAVE3/β-catenin oncogenic signaling regulates chemoresistance in triple negative breast cancer
W Wang, PS Rana, V Markovic, K Sossey-Alaoui
Breast Cancer Research 25 (1), 31, 2023
32023
The WAVE2/miR-29/integrin-β1 oncogenic signaling axis promotes tumor growth and metastasis in triple-negative breast cancer
PS Rana, W Wang, V Markovic, J Szpendyk, ER Chan, K Sossey-Alaoui
Cancer Research Communications 3 (1), 160-174, 2023
32023
Current and emerging strategies to treat urothelial carcinoma
B Rani, JJ Ignatz-Hoover, PS Rana, JJ Driscoll
Cancers 15 (19), 4886, 2023
22023
The NOGO receptor NgR2, a novel αVβ3 integrin effector, induces neuroendocrine differentiation in prostate cancer
F Quaglia, SR Krishn, K Sossey-Alaoui, PS Rana, E Pluskota, PH Park, ...
Scientific Reports 12 (1), 18879, 2022
22022
Abstract P1-06-02: Targeted deletion of Kindlin-2 in mouse mammary glands inhibits tumor growth, invasion and metastasis downstream of TGF-β/EGF oncogenic signaling pathway
P Rana, W Wang, A Alkrekchi, K Bialkowska, V Markovic, EF Plow, ...
Cancer Research 82 (4_Supplement), P1-06-02-P1-06-02, 2022
22022
Vactosertib, a novel TGF-β type I receptor kinase inhibitor, improves T-cell fitness: a single-arm, phase 1b trial in relapsed/refractory multiple myeloma
J Driscoll, E Malek, P Rana, M Swamydas, M Daunov, M Miyagi, ...
12023
Shutting off the fuel supply to target metabolic vulnerabilities in multiple myeloma
PS Rana, K Goparaju, JJ Driscoll
Frontiers in Oncology 13, 1141851, 2023
12023
系统目前无法执行此操作,请稍后再试。
文章 1–20